| Reduction of intimal hyperplasia in injured rat arteries promoted by catheter balloons coated with polyelectrolyte multilayers that contain plasmid DNA encoding PKCδ. | |
| | |
MedLine Citation:
|
PMID: 23069712 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
New therapeutic approaches that eliminate or reduce the occurrence of intimal hyperplasia following balloon angioplasty could improve the efficacy of vascular interventions and improve the quality of life of patients suffering from vascular diseases. Here, we report that treatment of arteries using catheter balloons coated with thin polyelectrolyte-based films ('polyelectrolyte multilayers', PEMs) can substantially reduce intimal hyperplasia in an in vivo rat model of vascular injury. We used a layer-by-layer (LbL) process to coat the surfaces of inflatable catheter balloons with PEMs composed of nanolayers of a cationic poly(β-amino ester) (polymer 1) and plasmid DNA (pPKCδ) encoding the δ isoform of protein kinase C (PKCδ), a regulator of apoptosis and other cell processes that has been demonstrated to reduce intimal hyperplasia in injured arterial tissue when administered via perfusion using viral vectors. Insertion of balloons coated with polymer 1/pPKCδ multilayers into injured arteries for 20 min resulted in local transfer of DNA and elevated levels of PKCδ expression in the media of treated tissue three days after delivery. IFC and IHC analysis revealed these levels of expression to promote downstream cellular processes associated with up-regulation of apoptosis. Analysis of arterial tissue 14 days after treatment revealed polymer 1/pPKCδ-coated balloons to reduce the occurrence of intimal hyperplasia by ~60% compared to balloons coated with films containing empty plasmid vectors. Our results demonstrate the potential therapeutic value of this nanotechnology-based approach to local gene delivery in the clinically important context of balloon-mediated vascular interventions. These PEM-based methods could also prove useful for other in vivo applications that require short-term, surface-mediated transfer of plasmid DNA. |
| | |
Authors:
|
Shane L Bechler; Yi Si; Yan Yu; Jun Ren; Bo Liu; David M Lynn |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2012-10-13 |
Journal Detail:
|
Title: Biomaterials Volume: 34 ISSN: 1878-5905 ISO Abbreviation: Biomaterials Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2012-10-29 Completed Date: 2013-03-26 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 8100316 Medline TA: Biomaterials Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 226-36 Citation Subset: IM |
Copyright Information:
|
Copyright © 2012 Elsevier Ltd. All rights reserved. |
Affiliation:
|
Department of Chemical and Biological Engineering, University of Wisconsin - Madison, Madison, WI 53706, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Balloon, Coronary
/
adverse effects* Animals Carotid Arteries / drug effects, pathology Carotid Artery Injuries / etiology*, pathology, prevention & control* Coated Materials, Biocompatible / pharmacology* DNA / metabolism* Electrolytes / chemistry Fluorescent Antibody Technique Gene Transfer Techniques Hyperplasia In Situ Nick-End Labeling Male Microscopy, Fluorescence Plasmids / metabolism Polymers / chemistry Protein Kinase C-delta / metabolism* Rats Rats, Sprague-Dawley Tunica Intima / drug effects, pathology* |
| Grant Support | |
ID/Acronym/Agency:
|
R01 EB006820/EB/NIBIB NIH HHS; R01 EB006820/EB/NIBIB NIH HHS; R01 HL081424/HL/NHLBI NIH HHS; R01 HL081424/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Coated Materials, Biocompatible; 0/Electrolytes; 0/Polymers; 9007-49-2/DNA; EC 2.7.11.13/Protein Kinase C-delta |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The blood and vascular cell compatibility of heparin-modified ePTFE vascular grafts.
Next Document: The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor ...